Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson’s disease

Lars Tatenhorst, Fabian Maass, Hannah Paul, Vivian Dambeck, Mathias Bähr, Rosanna Dono, Paul Lingor

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson’s disease'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology